Brian Freie
-
- Carcinogens and Genotoxicity Assessment 3
- Hematology top 10%
-
- DNA Repair Mechanisms 10
- CRISPR and Genetic Engineering 4
- Epigenetics and DNA Methylation 3
- Pluripotent Stem Cells Research 2
-
- Cancer-related Molecular Pathways 3
-
- Virus-based gene therapy research 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Robert N. EisenmanHaritha MathsyarajaPatrick A. CarrollD. Wade ClappSamantha CicconeXiaxin LiSuk‐Hee LeeLaura S. Haneline
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Brian Freie
23 papers receiving 775 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 155
- Hematology 104
- Molecular Biology 588
- Oncology 140
- Cell Biology 80
Countries citing papers authored by Brian Freie
This map shows the geographic impact of Brian Freie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Freie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Freie more than expected).
Fields of papers citing papers by Brian Freie
This network shows the impact of papers produced by Brian Freie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Freie. The network helps show where Brian Freie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Freie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2021 | 24 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 51 | |
| 6 | 2019 | 34 | |
| 7 | 2018 | 191 | |
| 8 | 2008 | 43 | |
| 9 | 2005 | 49 | |
| 10 | 2004 | 56 | |
| 11 | 2004 | 30 | |
| 12 | 2004 | 44 | |
| 13 | 2004 | 30 | |
| 14 | 2003 | 59 | |
| 15 | 2003 | 28 | |
| 16 | 2001 | 16 | |
| 17 | Variation in long-term engraftment of a large consecutive series of lambs transplanted in utero with human hematopoietic cells. | 1997 | 7 |
| 18 | 1996 | 10 | |
| 19 | Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells. | 1995 | 32 |
| 20 | 1995 | 7 |
About Brian Freie
Brian Freie is a scholar working on Cancer Research, Transplantation, Molecular Biology, Genetics and Oncology, having authored 23 papers that have together received 782 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers), Pluripotent Stem Cells Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cancer Research (155 citations), Hematology (104 citations), Molecular Biology (588 citations), Oncology (140 citations) and Cell Biology (80 citations). Brian Freie has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert N. Eisenman, Haritha Mathsyaraja, Patrick A. Carroll, D. Wade Clapp, Samantha Ciccone, D. Wade Clapp, Xiaxin Li, Suk‐Hee Lee, Laura S. Haneline and Attilio Orazi. Their work appears in journals such as Blood, Journal of Biological Chemistry, Cell Transplantation, Genes & Development and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.